We are live on ! Find out more
TC

TFS Capital Portfolio holdings

AUM $255M Turnover 65.26%
1-Year Est. Return 32.31%
This Fund
S&P 500
This Quarter Est. Return
+4.78%
1 Year Est. Return
+32.31%
3 Year Est. Return
+53.78%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$255M
AUM Growth
-$53M
Cap. Flow
-$59.9M
Cap. Flow %
-23.49%
Top 10 Hldgs %
4.95%
Holding
921
New
282
Increased
115
Reduced
203
Closed
319
Avg Time Held
0.4 years
Top 10 Avg Time Held
0.1 years
Top 20 Avg Time Held
0.1 years

Sector Composition

Rank Sector Weight
1 Healthcare 21.14%
2 Industrials 16.14%
3 Consumer Discretionary 14.21%
4 Technology 13.68%
5 Financials 8.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VBIV icon
551
DELISTED
VBI Vaccines
VBIV
$99K 0.04%
759
+374
+97% +$50.5K
2017 Q1
1 quarter
ARLZ
552
DELISTED
Aralez Pharmaceuticals
ARLZ
$97K 0.04%
+71,556
New +$103K
2017 Q2
0 quarters
EIGR
553
DELISTED
Eiger BioPharmaceuticals
EIGR
$96K 0.04%
+404
New +$91.8K
2017 Q2
0 quarters
CGI
554
DELISTED
Celadon Group
CGI
$95K 0.04%
+30,245
New +$94.7K
2017 Q2
0 quarters
ARCO icon
555
Arcos Dorados Holdings
ARCO
$1.36B
$93K 0.04%
12,854
+396
+3% +$3.21K
2016 Q1
5 quarters
ESXB
556
DELISTED
Community Bankers Trust
ESXB
$92K 0.04%
+11,122
New +$89.2K
2017 Q2
0 quarters
NWY
557
DELISTED
New York & Co
NWY
$92K 0.04%
66,730
+45,867
+220% +$70.1K
2016 Q4
2 quarters
LYTS icon
558
LSI Industries
LYTS
$508M
$91K 0.04%
10,026
-10,201
-50% -$92.4K
2017 Q1
1 quarter
RMT icon
559
Royce Micro-Cap Trust
RMT
$626M
$88K 0.03%
+10,200
New +$87.6K
2017 Q2
0 quarters
CRHM
560
DELISTED
CRH Medical
CRHM
$88K 0.03%
+15,418
New +$100K
2017 Q2
0 quarters
BCLI icon
561
DELISTED
Brainstorm Cell Therapeutics
BCLI
$87K 0.03%
+1,396
New +$86K
2017 Q2
0 quarters
PCYO icon
562
Pure Cycle
PCYO
$233M
$86K 0.03%
+11,111
New +$80.1K
2017 Q2
0 quarters
RIGL icon
563
Rigel Pharmaceuticals
RIGL
$755M
$86K 0.03%
3,142
-714
-19% -$19.5K
2016 Q4
2 quarters
AXTI icon
564
AXT
AXTI
$2.01B
$85K 0.03%
13,442
-60,212
-82% -$394K
2016 Q2
4 quarters
GORO icon
565
Goldgroup Mining
GORO
$502M
$84K 0.03%
+5,132
New +$78.1K
2017 Q2
0 quarters
NL icon
566
NLI Holdings
NL
$361M
$83K 0.03%
+11,707
New +$92K
2017 Q2
0 quarters
QHC
567
DELISTED
Quorum Health
QHC
$83K 0.03%
19,964
-2,926
-13% -$12K
2017 Q1
1 quarter
JNP
568
DELISTED
Juniper Pharmaceuticals
JNP
$83K 0.03%
16,490
-15,129
-48% -$67.7K
2016 Q3
3 quarters
DWSN icon
569
Dawson Geophysical
DWSN
$48.2M
$80K 0.03%
21,400
+2,904
+16% +$12.7K
2017 Q1
1 quarter
HBP
570
DELISTED
Huttig Building Products
HBP
$79K 0.03%
11,244
-13,549
-55% -$100K
2016 Q4
2 quarters
SIGM
571
DELISTED
Sigma Designs
SIGM
$78K 0.03%
+13,265
New +$80.3K
2017 Q2
0 quarters
CPSS icon
572
Consumer Portfolio Services
CPSS
$193M
$77K 0.03%
+16,959
New +$76.7K
2017 Q2
0 quarters
OXSQ icon
573
Oxford Square Capital
OXSQ
$72.6M
$77K 0.03%
12,135
– –
2017 Q1
1 quarter
INTT icon
574
inTEST
INTT
$140M
$75K 0.03%
+11,270
New +$82K
2017 Q2
0 quarters
LFVN icon
575
LifeVantage
LFVN
$52.6M
$75K 0.03%
+17,423
New +$76.8K
2017 Q2
0 quarters

Similar funds

TFS Capital's Q2 2017 Portfolio in Review

As of Q2 2017, TFS Capital held 921 positions worth $255M, down 17% from $308M the previous quarter. Its ten largest holdings account for 4.9% of the portfolio.

TFS Capital withdrew a net $59.9M in Q2 2017, closing 319 positions and reducing 203 holdings. Its most notable exit was ePlus, an estimated $1.71M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, TFS Capital opened a new position in MYR Group worth $1.06M.

  • TFS Capital's largest Q2 2017 buy was MYR Group: 34,070 shares worth $1.06M.
  • TFS Capital added most to ModivCare in Q2 2017, an estimated $871K increase.
  • TFS Capital's biggest Q2 2017 reduction was Insight Enterprises, cutting an estimated $1.31M.
  • TFS Capital fully exited ePlus in Q2 2017, selling an estimated $1.71M.
  • TFS Capital's ten largest holdings make up 4.9% of its $255M portfolio in Q2 2017.
  • TFS Capital opened 282 new positions and closed 319 in Q2 2017.
  • TFS Capital's portfolio value fell 17% quarter-over-quarter to $255M.

Based on TFS Capital's 13F filing for Q2 2017, filed 11 Aug 2017.